Raymond James cut shares of Canfor (TSE:CFP – Free Report) from a strong-buy rating to an outperform rating in a report released on Tuesday morning, BayStreet.CA reports. They currently have C$23.00 target price on the stock, down from their previous target price of C$25.00.
A number of other research analysts also recently issued reports on the stock. CIBC decreased their price target on shares of Canfor from C$28.00 to C$23.00 and set an outperform rating for the company in a research note on Friday, October 13th. TD Securities decreased their price target on shares of Canfor from C$24.00 to C$23.00 and set a buy rating for the company in a research note on Monday, November 6th. Scotiabank set a C$22.00 price target on shares of Canfor and gave the stock a sector perform rating in a research note on Monday, January 22nd. Finally, Royal Bank of Canada reduced their price objective on shares of Canfor from C$30.00 to C$27.00 and set an outperform rating for the company in a research report on Friday, October 20th. One equities research analyst has rated the stock with a hold rating and four have issued a buy rating to the stock. According to MarketBeat.com, Canfor currently has a consensus rating of Moderate Buy and a consensus target price of C$23.60.
Canfor Trading Down 1.8 %
Canfor Company Profile
Canfor Corporation operates as an integrated forest products company in the United States, Asia, Canada, Europe, and internationally. It operates in two segments, Lumber, and Pulp and Paper. The company manufactures and sells finger-jointed lumber, engineered wood products, wood chips and pellets, and logs, as well as custom specialty products, including strength-rated trusses, beams, and tongue-and-groove timber; and generates green energy.
- Five stocks we like better than Canfor
- What is the Euro STOXX 50 Index?
- Is the dip in Atlassian stock a sneaky buy opportunity?
- Overbought Stocks Explained: Should You Trade Them?
- Caterpillar stock hits new highs; time to ring the register?
- How to Read Stock Charts for Beginners
- 5 medical stocks growing earnings by triple digits
Receive News & Ratings for Canfor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Canfor and related companies with MarketBeat.com's FREE daily email newsletter.